KPTI   $0.87  2.35% Market Closed After Close 0.92 5.75%

Karyopharm Therapeutics Inc
Total Cash 152.12M
totalCashPerShare 1.22
EBITDA -130.61M
Total Debt 269.13M
quickRatio 3.31
currentRatio 3.619
Total Revenue 145.67M
debtToEquity
Revenue/Share 1.251
ROA -0.31982002
ROE
grossProfits
freeCashflow -79.55M
operatingCashflow -130.34M
earningsGrowth
revenueGrowth 0.139
grossMargins 0.89185995
ebitdaMargins -0.89666003
operatingMargins -0.65722
profitMargins -0.61724997
enterpriseValue 225.49M
forwardPE -1.2986567
floatShares 123.03M
sharesOutstanding 124.68M
sharesShort 18.60M
sharesShortPriorMonth 18.52M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.57%
Short Ratio help_outline 28.47%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue -1.06
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -89.91M
trailingEps -1.14%
forwardEps -0.67%
enterpriseToEbitda -1.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.26 3Q 2024
institutionsCount 137
lastUpdated Oct. 21, 2024, 1:28 p.m.